Pulnovo Medical Announces First Two U.S. Patients Enrolled in PULSE-LHD IDE Clinical Trial of Pulmonary Artery Denervation in Treating Pulmonary Hypertension Associated with Left Heart Disease

Trial StartPulmonary Artery DenervationPositive

AI Analysis

Summary

Pulnovo Medical announced enrollment of the first two U.S. patients in its PULSE-LHD IDE clinical trial evaluating pulmonary artery denervation for treating pulmonary hypertension associated with left heart disease.

Clinical Trial Data

Patients

Outcome Details

First two U.S. patients enrolled in PULSE-LHD IDE clinical trial

Importance:3/10

Sentiment:

0.30

clinical trialpulmonary hypertensionheart failureIDEmedical devicepatient enrollment

Related Companies

$MDCE $TRAX

Read the original article

Published by PR Newswire Biotech on August 24, 2026 3:05 AM

Read Original